San Diego-based CoDA Therapeutics, a developer of chronic wound healing biopharmaceuticals, announced this morning that it has raised $19.2M in a series B financing round. The round came from Domain Associates, GBS Venture Partners and BioPacificVentures. CODA said that it expects additional series B funding from additional investors at a future date. The new funding will go towards further development of its products. More information »